B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey
Received 8 April 2019
Accepted for publication 20 September 2019
Published 20 December 2019 Volume 2019:15 Pages 559—569
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Konstantinos Tziomalos
Obiageli Uzoamaka Onyemelukwe, 1 Albert Imhoagene Oyati, 1 Solomon Sulei Danbauchi, 2 Austine Obasohan 3
1Department of Medicine, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria; 2Department of Medicine, Jos University Teaching Hospital, Jos-Plateau State, Nigeria; 3Department of Medicine, University of Benin Teaching Hospital, Benin, Edo State, Nigeria
Correspondence: Obiageli Uzoamaka Onyemelukwe
Department of Medicine, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
Tel +234 8187351600
Background: The study aimed at determining the response of BNP and tissue Doppler (TD) E/e´ to standard heart failure (HF) therapy in an African black population as data on these are lacking in Africa. BNP assessment in relation to HF severity and its association with its predictors were also determined.
Methods: It was a longitudinal-analytical study with a one month follow-up among 100 HF patients seen at Ahmadu Bello University Teaching Hospital, Zaria-Nigeria. Two-way Repeated Measures ANOVA determined BNP levels before and after treatment according to the HF severity. Wilcoxon-Signed Ranks test determined the difference in BNP and TD E/e´ before and after treatment. Pearson’s correlation assessed log-transformed BNP’s association with its predictors.
Results: BNP significantly (p< 0.001) rose with increasing severity of HF from 386.6 ± 186.5 pg/mL to 581.7 ± 299.0 pg/mL to 805.0 ± 484.0 pg/mL in the NYHA II-IV HF, respectively, with consequent fall in a similar fashion following treatment. The Median (IQR) BNP levels reduced significantly (p< 0.001) from 450 (362.5, 712.5) to 275.0 (225, 375.2) pg/mL with a 38.9% reduction over 4 weeks associated with significant improvement in TD E/e´, structural and functional parameters. Ln 10BNP was significantly (p< 0.001) positively correlated to TD E/e´ before (r=0.51) and after treatment (r=0.43). Likewise, Ln 10BNP was significantly (p< 0.05) negatively correlated to ejection fraction & fractional shortening before and after treatment.
Conclusion: BNP and tissue Doppler can serve as useful tools in the assessment of the effectiveness of African HF treatment and functional capacity over 4 weeks. TD E/e´ may be a reliable non-invasive estimate of left ventricular filling pressures and diastolic dysfunction.
Keywords: B-type natriuretic peptide, pulsed tissue doppler, left ventricular filling pressure, African heart failure, before and after 4 weeks standard therapy
Corrigendum for this paper has been published
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]